Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Kagoshima, Japan Clinical Trials

A listing of Kagoshima, Japan clinical trials actively recruiting patients volunteers.

RESULTS

Found (4) clinical trials

The Effect on the Pharmacokinetics of Desmopressin Oral Lyophilisate by Food and by Gender

This trial is divided in two parts investigating the effect of food and the effect of gender, respectively, on the pharmacokinetics of desmopressin administered as oral lyophilisate. Desmopressin will be administered as a single oral lyophilisate 120 µg dose in all treatment periods.

Phase

0.0 miles

Learn More »

A Phase 1 Study Of Talazoparib PARP Inhibitor In Japanese Patients With Advanced Solid Tumors

This is a Phase 1 study which consists of 2 parts; Dose Escalation part and Expansion part. The dose escalation part is openlabel, and evaluates safety, preliminary efficacy and PK of singleagent talazoparib in sequential cohorts of adult patients with advanced solid tumors who are resistant to standard therapy or ...

Phase

0.67 miles

Learn More »

Safety of Itacitinib in Combination With Corticosteroids for Treatment of Steroid-Naive Acute Graft-Versus-Host Disease in Japanese Subjects

The purpose of this study is to assess the safety and tolerability of itacitinib in combination with corticosteroids in Japanese subjects with Grades II to IV acute graft-versus-host disease (aGVHD).

Phase

2.82 miles

Learn More »

DS-3201b in Participants With Lymphomas

DS-3201b is an experimental drug. It is not approved for regular use. It can only be used in clinical research. Adults with non-Hodgkin lymphoma (NHL) might be able to join this study if their disease: has come back after remission is not responding to current treatment This study has two ...

Phase

2.89 miles

Learn More »